Skip to main content

Zijun Yidan Xu-Monette

Assistant Professor in Pathology
Pathology
905 S LaSalle St, Snyderman GSRB1, Room 1010, Durham, NC 27710
905 S LaSalle St, Snyderman GSRB1, Room 1010, Durham, NC 27710

Overview


My research efforts have been focused on identifying prognostic and therapeutic biomarkers in B-cell lymphoma. My research interests also include investigation of molecular and immune mechanisms underlying the poor clinical outcomes of lymphoma, the pathogenesis and evolution of drug resistant clones, and development of novel therapies for aggressive B-cell lymphoma.

Current Appointments & Affiliations


Assistant Professor in Pathology · 2021 - Present Pathology, Clinical Science Departments
Member of the Duke Cancer Institute · 2019 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis.

Journal Article Blood Adv · March 10, 2026 Pyroptosis is a form of programmed cell death characterized by the cleavage of the gasdermin (GSDM) family proteins that form pores in the plasma membrane, cell rupture, and the release of proinflammatory cytokines. In this study, we performed immunohistoc ... Full text Link to item Cite

Hi-c FFPE sequencing analysis is highly concordant with FISH and detects additional variants informing diagnosis and treatment in diffuse large B-cell lymphoma

Conference Blood · November 3, 2025 AbstractBackground:Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL), accounting for ... Full text Cite

Multi-endpoint AI morphology model (MEAM) enhances risk prediction for vascular events and disease progression in MPNs

Conference Blood · November 3, 2025 AbstractINTRODUCTIONThe myeloproliferative neoplasms (MPNs) are clonal haematological disorders that ... Full text Cite
View All Publications

Recent Grants


PD-L1 Modifications in Cancer Diagnosis and Treatment

ResearchCo Investigator · Awarded by Baylor College of Medicine · 2025 - 2030

Spatially resolved, single cell biomarkers of B cell lymphoma

ResearchCo Investigator · Awarded by Cedars Sinai Medical Center · 2022 - 2026

Genetic and Epigenetic Biomarkers for B-cell Lymphoma

ResearchCo Investigator · Awarded by National Institutes of Health · 2020 - 2025

View All Grants

Education


Michigan Technological University · 2009 Ph.D.